Eupraxia Pharmaceuticals Inc (EPRX) — Financial Flexibility Index
Eupraxia Pharmaceuticals Inc (EPRX) has a Financial Flexibility Index of -0.82x as of September 2025. Free cash flow of CA$-4.45 Million (operating CF CA$-4.51 Million minus capex CA$60.38K) represents -1% of total liabilities (CA$5.43 Million). Check asset allocation strategy of Eupraxia Pharmaceuticals Inc to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Eupraxia Pharmaceuticals Inc Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Eupraxia Pharmaceuticals Inc across 8 annual periods. See Eupraxia Pharmaceuticals Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Eupraxia Pharmaceuticals Inc (2017–2024)
Year-by-year free cash flow to debt coverage for Eupraxia Pharmaceuticals Inc. For the full company profile including market capitalisation, see EPRX market cap.
| Year | Flexibility Index | Free Cash Flow (CAD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -6.70x | CA$-29.89 Million | CA$-29.99 Million | CA$4.46 Million | ▼ -514.5% |
| 2023 | -1.09x | CA$-27.84 Million | CA$-27.92 Million | CA$25.55 Million | ▲ +14.4% |
| 2022 | -1.27x | CA$-18.47 Million | CA$-18.78 Million | CA$14.51 Million | ▼ -4.5% |
| 2021 | -1.22x | CA$-14.21 Million | CA$-14.64 Million | CA$11.67 Million | ▼ -101558.9% |
| 2020 | 0.00x | CA$27.75K | CA$-403.93K | CA$23.12 Million | ▲ +100.5% |
| 2019 | -0.24x | CA$-5.16 Million | CA$-5.17 Million | CA$21.42 Million | ▲ +57.7% |
| 2018 | -0.57x | CA$-8.18 Million | CA$-8.32 Million | CA$14.34 Million | ▲ +91.6% |
| 2017 | -6.77x | CA$-4.98 Million | CA$-5.30 Million | CA$735.82K | — |